InsidersTradesSigma
Browse the full record of transactions filed by Redmond Cavan M., Director. Officer active across 1 companies, notably OncoCyte Corp. In total, 1 reports have been logged. Total volume traded: €43k. The latest transaction was disclosed on 16 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Cavan M. Redmond serves as a Director at OncoCyte Corp. In this role, he participates in the governance of the company and strategic decision-making. His experience in the healthcare sector enables him to provide valuable insights to board discussions. He plays an active role in guiding the policies and strategies of the company.